These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3337904)

  • 21. [Secondary leukemia].
    Urbańska-Ryś H; Robak T; Krykowski E
    Acta Haematol Pol; 1992; 23(2):71-7. PubMed ID: 1488863
    [No Abstract]   [Full Text] [Related]  

  • 22. Complex chromosomal abnormalities in acute nonlymphocytic leukemia.
    Levin M; Le Coniat M; Bernheim A; Berger R
    Cancer Genet Cytogenet; 1986 Jun; 22(2):113-9. PubMed ID: 3708547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fourth International Workshop on Chromosomes in Leukemia 1982: Secondary leukemias associated with neoplasia: treated and untreated.
    Sandberg AA; Vuopio P
    Cancer Genet Cytogenet; 1984 Mar; 11(3):319-21. PubMed ID: 6704935
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of chromosome abnormalities in leukemia.
    Lawler SD
    Semin Hematol; 1982 Oct; 19(4):257-72. PubMed ID: 6760404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
    Johansson B; Mertens F; Mitelman F
    Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
    Michalová K; Musilová J; Zemanová Z
    Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic markers in hematoproliferative disorders.
    Fonatsch C
    Blut; 1985 Nov; 51(5):315-28. PubMed ID: 3864500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic analysis in 941 consecutive patients with haematologic disorders.
    Billström R; Nilsson PG; Mitelman F
    Scand J Haematol; 1986 Jul; 37(1):29-40. PubMed ID: 3464085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy associated leukaemia.
    Devereux S
    Blood Rev; 1991 Sep; 5(3):138-45. PubMed ID: 1777746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome abnormalities in secondary myelodysplastic syndromes.
    Bloomfield CD
    Scand J Haematol Suppl; 1986; 45():82-90. PubMed ID: 3515525
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease.
    Löfvenberg E; Nordenson I; Wahlin A
    Cancer Genet Cytogenet; 1990 Oct; 49(1):57-67. PubMed ID: 2397474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.
    Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Noens L; Bosly A; Louwagie A; Van Den Berghe H
    Cancer Genet Cytogenet; 1989 Dec; 43(2):227-41. PubMed ID: 2598167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postleukemic dysmyelopoiesis.
    Foucar K; Vaughan WP; Armitage JO; Patil S; Dick F; Karp JE
    Am J Hematol; 1983 Dec; 15(4):321-34. PubMed ID: 6650493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy.
    Pintado T; Ferro MT; San Román C; Mayayo M; Laraña JG
    Cancer; 1985 Feb; 55(3):535-41. PubMed ID: 3965107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of the short arm of chromosome 12 in acute nonlymphocytic leukemia and dysmyelopoietic syndrome.
    Berger R; Bernheim A; Le Coniat M; Vecchione D; Pacot A; Daniel MT; Flandrin G
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):281-9. PubMed ID: 3943049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
    Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
    Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary myelodysplastic syndromes and leukaemias.
    Levine EG; Bloomfield CD
    Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.
    Fayad L; Kantarjian H; O'Brien S; Seong D; Albitar M; Keating M; Talpaz M
    Leukemia; 1997 May; 11(5):767-71. PubMed ID: 9180306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.